{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:28:00Z","timestamp":1790882880219,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T00:00:00Z","timestamp":1607558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.vaccine.2020.11.067","type":"journal-article","created":{"date-parts":[[2020,12,25]],"date-time":"2020-12-25T02:41:52Z","timestamp":1608864112000},"page":"605-616","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Meningococcal disease epidemiology in Brazil (2005\u20132018) and impact of MenC vaccination"],"prefix":"10.1016","volume":"39","author":[{"given":"Altac\u00edlio","family":"Aparecido Nunes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"De Jesus Lopes De Abreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otavio","family":"Cintra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"A.C.T. Cintra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Barbosa Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana","family":"Nogueira Castro De Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.11.067_b0005","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.apjtm.2017.10.004","article-title":"Meningococcal disease, a clinical and epidemiological review","volume":"10","author":"Batista","year":"2017","journal-title":"Asian Pac J Trop Med"},{"key":"10.1016\/j.vaccine.2020.11.067_b0010","doi-asserted-by":"crossref","first-page":"6529","DOI":"10.1016\/j.vaccine.2015.10.055","article-title":"The current situation of meningococcal disease in Latin America and updated Global Meningococcal Initiative (GMI) recommendations","volume":"33","author":"Safadi","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.11.067_b0015","first-page":"e118","article-title":"Knowing the scope of meningococcal disease in Latin America","volume":"41","author":"S\u00e1fadi","year":"2017","journal-title":"Rev Panam Salud Publica"},{"key":"10.1016\/j.vaccine.2020.11.067_b0020","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/INF.0000000000000228","article-title":"A consensus statement: meningococcal disease among infants, children and adolescents in Latin America","volume":"33","author":"Ruttimann","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2020.11.067_b0025","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijid.2019.01.009","article-title":"Epidemiological burden of meningococcal disease in Brazil: A systematic literature review and database analysis","volume":"80","author":"Presa","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.11.067_b0030","doi-asserted-by":"crossref","first-page":"e64524","DOI":"10.1371\/journal.pone.0064524","article-title":"Bacterial meningitis in Brazil: baseline epidemiologic assessment of the decade prior to the introduction of pneumococcal and meningococcal vaccines","volume":"8","author":"Azevedo","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.11.067_b0035","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/14760584.2017.1258308","article-title":"The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection","volume":"16","author":"Borrow","year":"2017","journal-title":"Expert Rev Vacc"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2020.11.067_b0040","doi-asserted-by":"crossref","first-page":"B3","DOI":"10.1016\/j.vaccine.2011.12.062","article-title":"Meningococcal disease: clinical presentation and sequelae","volume":"30","author":"Pace","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.11.067_b0045","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jadohealth.2016.04.012","article-title":"The global evolution of meningococcal epidemiology following the introduction of meningococcal vaccines","volume":"59","author":"Pelton","year":"2016","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.vaccine.2020.11.067_b0050","doi-asserted-by":"crossref","unstructured":"Crum-Cianflone N, Sullivan E. Meningococcal Vaccinations. Infect Dis Ther. 2016;5:89\u2013112.","DOI":"10.1007\/s40121-016-0107-0"},{"key":"10.1016\/j.vaccine.2020.11.067_b0055","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1016\/j.vaccine.2011.02.058","article-title":"The global meningococcal initiative: recommendations for reducing the global burden of meningococcal disease","volume":"29","author":"Harrison","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.11.067_b0060","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1097\/INF.0000000000000853","article-title":"Prevalence, risk factors and molecular characteristics of meningococcal carriage among Brazilian adolescents","volume":"34","author":"Cassio de Moraes","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2020.11.067_b0065","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.bjid.2017.06.005","article-title":"A cross-sectional study assessing the pharyngeal carriage of Neisseria meningitidis in subjects aged 1\u201324 years in the city of Embu das Artes, Sao Paulo Brazil","volume":"21","author":"Weckx","year":"2017","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.11.067_b0070","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/jpids\/piu027","article-title":"Meningococcal disease: epidemiology and early effects of immunization programs","volume":"3","author":"Safadi","year":"2014","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.vaccine.2020.11.067_b0075","doi-asserted-by":"crossref","first-page":"e0166475","DOI":"10.1371\/journal.pone.0166475","article-title":"Meningococcal carriage among adolescents after mass meningococcal C conjugate vaccination campaigns in Salvador Brazil","volume":"11","author":"Nunes","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.11.067_b0080","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1128\/JCM.02510-06","article-title":"Clonal distribution of invasive Neisseria meningitidis serogroup C strains circulating from 1976 to 2005 in greater Sao Paulo Brazil","volume":"45","author":"de Lemos","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2020.11.067_b0085","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jinf.2008.07.014","article-title":"High prevalence of Neisseria meningitidis hypervirulent lineages and emergence of W135:P1.5,2:ST-11 clone in Southern Brazil","volume":"57","author":"Weidlich","year":"2008","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2020.11.067_b0090","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.3201\/eid1911.130610","article-title":"Three outbreak-causing Neisseria meningitidis serogroup C clones Brazil","volume":"19","author":"Barroso","year":"2013","journal-title":"Emerg Infect Dis."},{"key":"10.1016\/j.vaccine.2020.11.067_b0095","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.micinf.2017.09.010","article-title":"Dissemination of the ST-103 clonal complex serogroup C meningococci in Salvador Brazil","volume":"20","author":"Cordeiro","year":"2018","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2020.11.067_b0100","unstructured":"Minist\u00e9rio da Sa\u00fade, Brasil. Departamento de Vigil\u00e2ncia Epidemiol\u00f3gica, Coordena\u00e7\u00e3o Geral do Programa Nacional de Imuniza\u00e7oes. Introdu\u00e7\u00e3o da vacinameningoc\u00f3cica C conjugada no calend\u00e1rio de vacina\u00e7\u00e3o da crian\u00e7a. Incorpora\u00e7\u00e3o - 2nd semestre de 2010. Bras\u00edlia, Julho 2010. Available at: http:\/\/www.sgc.goias.gov.br\/upload\/links\/arq_626_menig.pdf."},{"key":"10.1016\/j.vaccine.2020.11.067_b0105","unstructured":"Minist\u00e9rio da Sa\u00fade, Brasil. Nota Informativa sobre mudancas no calendario Nacional de vacinacao para o ano de 2017. Available at: http:\/\/portalarquivos2.saude.gov.br\/images\/pdf\/2016\/dezembro\/28\/Nota-Informativa-384-Calendario-Nacional-de-Vacinacao-2017.pdf."},{"key":"10.1016\/j.vaccine.2020.11.067_b0110","unstructured":"Minist\u00e9rio da Sa\u00fade, Brasil. Departamento de Vigil\u00e2ncia Epidemiol\u00f3gica, Coordena\u00e7\u00e3o Geral do Programa Nacional de Imuniza\u00e7oes. Informe t\u00e9cnico da amplia\u00e7\u00e3o da oferta das vacinas papilomav\u00edrus humano 6,11, 16 e 18 (recombinante) \u2013 vacina HPV quadrivalente e meningoc\u00f3cica C (conjugada). Bras\u00edlia, Marco 2018. Available at: http:\/\/portalarquivos2.saude.gov.br\/images\/pdf\/2018\/marco\/14\/Informe-T--cnico-HPV-MENINGITE.pdf."},{"key":"10.1016\/j.vaccine.2020.11.067_b0115","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.bjid.2013.11.012","article-title":"Meningococcal disease before and after the introduction of meningococcal serogroup C conjugate vaccine. Federal District, Brazil","volume":"18","author":"Tauil M de","year":"2014","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.11.067_b0120","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/j.vaccine.2017.03.010","article-title":"Impact of meningococcal C conjugate vaccination four years after introduction of routine childhood immunization in Brazil","volume":"35","author":"Andrade","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.11.067_b0125","unstructured":"IBGE. Brazilian demographic census. Brazil\u2019s population projection by sex and age: 2000-2060. Available at: http:\/\/www.ibge.gov.br\/home\/estatistica\/populacao\/projecao_da_populacao\/2013\/default_tab.shtm."},{"key":"10.1016\/j.vaccine.2020.11.067_b0130","unstructured":"Minist\u00e9rio da Sa\u00fade, Brasil. SINAN Departamento de Vigil\u00e2ncia Epidemiol\u00f3gica. Guia de vigil\u00e2ncia epidemiol\u00f3gica."},{"key":"10.1016\/j.vaccine.2020.11.067_b0135","first-page":"e2018335","article-title":"Evaluation of the national meningococcal disease surveillance system: Brazil, 2007\u20132017","volume":"28","author":"Ribeiro","year":"2019","journal-title":"Epidemiol Serv Saude"},{"key":"10.1016\/j.vaccine.2020.11.067_b0140","series-title":"CID-10 Classificac\u00e3o Estat\u00edstica Internacional de Doencas e Problemas Relacionados \u00e0 Sa\u00fade","author":"Organizac\u00e3o Mundial da Sa\u00fade \u2013","year":"2009"},{"key":"10.1016\/j.vaccine.2020.11.067_b0145","unstructured":"Brazil. DATASUS. Informa\u00e7\u00f5es de Sa\u00fade-Tabnet. Available at http:\/\/tabnet.datasus.gov.br\/cgi\/deftohtm.exe?pni\/cnv\/cpniuf.def."},{"key":"10.1016\/j.vaccine.2020.11.067_b0150","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1590\/0074-02760160173","article-title":"Evaluation of the impact of serogroup C meningococcal disease vaccination program in Brazil and its regions: a population-based study, 2001-2013","volume":"112","author":"Moraes","year":"2017","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.vaccine.2020.11.067_b0155","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1080\/21645515.2017.1415682","article-title":"Impact of meningococcal C conjugate vaccination programs with and without catch-up campaigns in adolescents: Lessons learned from Bahia, Brazil","volume":"14","author":"Evellyn do Macedo","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2020.11.067_b0160","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1016\/j.vaccine.2012.06.044","article-title":"Impact of vaccination during an epidemic of serogroup C meningococcal disease in Salvador, Brazil","volume":"30","author":"Cardoso","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.11.067_b0165","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1080\/21645515.2017.1391431","article-title":"Combined effect of PCV10 and meningococcal C conjugate vaccination on meningitis mortality among children under five years of age in Brazil","volume":"14","author":"Bierrenbach","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2020.11.067_b0170","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1080\/21645515.2019.1700710","article-title":"A critical analysis of serogroup B meningococcal disease burden in Brazil (2001-2015): implications for public health decisions","volume":"16","author":"Chicuto","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2020.11.067_b0175","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/cid\/ciu597","article-title":"The impact of the meningococcal serogroup C conjugate vaccine in Canada between 2002 and 2012","volume":"59","author":"Sadarangani","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2020.11.067_b0180","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/INF.0b013e31819040e7","article-title":"The impact of childhood meningococcal serogroup C conjugate vaccine programs in Canada","volume":"28","author":"Bettinger","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2020.11.067_b0185","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1086\/649209","article-title":"Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease","volume":"50","author":"Cohn","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2020.11.067_b0190","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1542\/peds.2014-2035","article-title":"Epidemiology of infant meningococcal disease in the United States, 2006-2012","volume":"135","author":"MacNeil","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2020.11.067_b0195","doi-asserted-by":"crossref","first-page":"E369","DOI":"10.33321\/cdi.2017.41.46","article-title":"Australian Meningococcal Surveillance Programme annual report, 2016","volume":"41","author":"Lahra","year":"2017","journal-title":"Commun Dis Intell Q Rep"},{"key":"10.1016\/j.vaccine.2020.11.067_b0200","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1016\/j.vaccine.2012.03.011","article-title":"Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccines","volume":"30","author":"Ladhani","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.11.067_b0205","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/j.vaccine.2017.03.007","article-title":"The epidemiology of invasive meningococcal disease in EU\/EEA countries, 2004-2014.","volume":"35","author":"Whittaker","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.11.067_b0210","first-page":"E116","article-title":"Epidemiology of Neisseria meningitidis infections: case distribution by age and relevance of carriage","volume":"56","author":"Gabutti","year":"2015","journal-title":"J Prev Med Hyg"},{"key":"10.1016\/j.vaccine.2020.11.067_b0215","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1016\/j.vaccine.2013.07.083","article-title":"Effectiveness of meningococcal serogroup C vaccine programmes","volume":"31","author":"Borrow","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.11.067_b0220","unstructured":"Estado de Santa Catarina. Diretoria de Vigil\u00e2ncia Epidemiol\u00f3gica. Boletim Epidemiol\u00f3gico n\u00b001\/2019 \u2013 Vigil\u00e2ncia da Doen\u00e7a Meningoc\u00f3cica. Available at: http:\/\/www.dive.sc.gov.br\/conteudos\/boletim2019\/BoletimMeningite01D2019\/BoletimDM01.2019.pdf."},{"key":"10.1016\/j.vaccine.2020.11.067_b0225","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1080\/21645515.2018.1532248","article-title":"Recent changes in the epidemiology of Neisseria meningitidis serogroup W across the world, current vaccination policy choices and possible future strategies","volume":"15","author":"Booy","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2020.11.067_b0230","doi-asserted-by":"crossref","first-page":"1800245","DOI":"10.2807\/1560-7917.ES.2019.24.14.1800245","article-title":"Increase of invasive meningococcal serogroup W disease in Europe, 2013 to 2017","volume":"24","author":"Krone","year":"2019","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2020.11.067_b0235","doi-asserted-by":"crossref","first-page":"6915","DOI":"10.1016\/j.vaccine.2019.09.050","article-title":"Meningococcal invasive disease by serogroup W and use of ACWY conjugate vaccines as control strategy in Chile","volume":"37","author":"Villena","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.11.067_b0240","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1586\/14760584.2016.1130628","article-title":"Routinely vaccinating adolescents against meningococcus: targeting transmission & disease","volume":"15","author":"Vetter","year":"2016","journal-title":"Expert Rev Vacc"},{"key":"10.1016\/j.vaccine.2020.11.067_b0245","doi-asserted-by":"crossref","first-page":"B20","DOI":"10.1016\/j.vaccine.2009.04.067","article-title":"Meningococcal C conjugate vaccine: the experience in England and Wales","volume":"27(Suppl 2)","author":"Campbell","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.11.067_b0250","doi-asserted-by":"crossref","first-page":"215","DOI":"10.5123\/S1679-49742014000200003","article-title":"Estimativas corrigidas de casos de meningite, Brasil 2008-2009","volume":"23","author":"Emmerick","year":"2014","journal-title":"Epidemiologia e Servi\u00e7os de Sa\u00fade"},{"key":"10.1016\/j.vaccine.2020.11.067_b0255","doi-asserted-by":"crossref","first-page":"104079","DOI":"10.1016\/j.meegid.2019.104079","article-title":"Molecular surveillance of brazilian meningococcal isolates serogroup c in the pre and post-men-c-vaccination period: Emergence of ST-3780","volume":"78","author":"Azevedo","year":"2020","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.vaccine.2020.11.067_b0260","doi-asserted-by":"crossref","first-page":"acmi000079","DOI":"10.1099\/acmi.0.000079","article-title":"Phenotypic characterization of Neisseria meningitidis strains isolated from invasive meningococcal disease in Brazil from 2002 to 2017","volume":"2","author":"Gorla","year":"2020","journal-title":"Access Microbiol"},{"key":"10.1016\/j.vaccine.2020.11.067_b0265","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.bjid.2020.06.007","article-title":"Trajectory of serogroups causing Invasive Meningococcal Disease in Santa Catarina state, Brazil (2007-2019)","volume":"24","author":"Feijo","year":"2020","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.11.067_b0270","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jinf.2020.05.079","article-title":"The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination","volume":"81","author":"Parikh","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2020.11.067_b0275","first-page":"42","article-title":"Actualizaci\u00f3n sobre enfermedad meningoc\u00f3cica y su prevenci\u00f3n [Update on meningococcal disease and its prevention]","volume":"60","author":"Bakira","year":"2018","journal-title":"Rev Hosp Ni\u00f1os (B Aires)"},{"key":"10.1016\/j.vaccine.2020.11.067_b0280","unstructured":"Neves U [New vaccine against meningitis is available in SUS] PEBMED; 09 July 2020: Available at: https:\/\/pebmed.com.br\/nova-vacina-contra-a-meningite-esta-disponivel-no-sus\/"},{"key":"10.1016\/j.vaccine.2020.11.067_b0285","unstructured":"Minist\u00e9rio da Sa\u00fade, Brasil. Coordena\u00e7\u00e3o de Monitoramento e Avalia\u00e7\u00e3o de Tecnologias em Sa\u00fade. Vacina meningoc\u00f3cica ACWY (conjugada) para adolescentes de 11 e 12 anos no Calend\u00e1rio Nacional de Vacina\u00e7\u00e3o. Relat\u00f3rio de recomenda\u00e7\u00e3o n.556. 2020. Available at: http:\/\/conitec.gov.br\/images\/Consultas\/Relatorios\/2020\/20201001_Relatorio_de_Recomendacao_556_Vacina_meningococica_ACWY.pdf."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20315425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20315425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:51:22Z","timestamp":1759402282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20315425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0264410X20315425"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.11.067","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meningococcal disease epidemiology in Brazil (2005\u20132018) and impact of MenC vaccination","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.11.067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 GlaxoSmithKline Biologicals SA. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}